VC-backed Eleven Biotherapeutics raises $50 mln for IPO
Biopharmaceutical company Eleven Biotherapeutics raised $50 million in its IPO after having priced its offering of 5 million shares at $10 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol "EBIO." Citigroup, Cowen and Company and Leerink Partners are the lead underwriters. Its backers include Third Rock Ventures, Flagship Ventures and Jafco.
7 February 2014•2 mins read
